Status:

COMPLETED

BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis

Lead Sponsor:

Meridian Bioscience, Inc.

Conditions:

Chronic Liver Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This trial is a pivotal trial to validate the use of a 13 C labeled substrate called methacetin and the BreathID automatic breath testing system, for determination of cirrhosis in patients with chroni...

Detailed Description

Patients with chronic liver disease who have a recent biopsy will be offered a breath test. Correlation will be shown between histology and breath test in determining cirrhosis.

Eligibility Criteria

Inclusion

  • Age \>18 with chronic liver disease

Exclusion

  • Patients that are taking hepatotoxin drug.
  • Patient with severe congestive heart failure
  • Patient with severe pulmonary hypertension
  • Patient with uncontrolled diabetes mellitus
  • Patient with previous surgical bypass surgery for morbid obesity
  • Patient with extensive small bowel resection
  • Patient currently receiving total parenteral nutrition
  • Patient is a recipients of any organ transplant
  • Patients that received any anti-viral treatment within the past year
  • Women who are pregnant
  • Patient allergic to acetaminophen (such as Tylenol or any other related medications)
  • Patient with history of chronic obstructive pulmonary disease or symptomatic bronchial asthma
  • Patients unable to sign informed consent
  • Patients that based on the opinion of the investigator should not be enrolled into this study
  • Patients that are participating in other clinical trials evaluating experimental treatments or procedures

Key Trial Info

Start Date :

August 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2009

Estimated Enrollment :

414 Patients enrolled

Trial Details

Trial ID

NCT00736840

Start Date

August 1 2008

End Date

September 1 2009

Last Update

January 12 2023

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

Cedars Sinai Medical Center

Los Angeles, California, United States, 90048

2

Henry Ford Health Sytem

Detroit, Michigan, United States, 48202

3

Cleveland Clinic

Cleveland, Ohio, United States, 44195

4

University of Pennsylvania Health System

Philadelphia, Pennsylvania, United States, 19104